Robert Gharavi

680 total citations
12 papers, 562 citations indexed

About

Robert Gharavi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Robert Gharavi has authored 12 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Robert Gharavi's work include Histone Deacetylase Inhibitors Research (5 papers), Mitochondrial Function and Pathology (3 papers) and Peptidase Inhibition and Analysis (3 papers). Robert Gharavi is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Mitochondrial Function and Pathology (3 papers) and Peptidase Inhibition and Analysis (3 papers). Robert Gharavi collaborates with scholars based in United States, Netherlands and South Korea. Robert Gharavi's co-authors include Mark P. Mattson, M. G. R. PITTA, Marc Gleichmann, Dong Liu, Peethambaran Arun, Madhusoodana P. Nambiar, David Tuck, Kevin R. Kelly, Manish R. Patel and Yasuhiro Oki and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Neurochemistry.

In The Last Decade

Robert Gharavi

12 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Gharavi United States 8 260 127 120 116 99 12 562
Aaron Long United States 11 284 1.1× 126 1.0× 264 2.2× 102 0.9× 117 1.2× 11 604
Xiongjin Chen China 12 269 1.0× 105 0.8× 160 1.3× 34 0.3× 124 1.3× 16 542
Hassina Massudi Australia 4 190 0.7× 81 0.6× 236 2.0× 129 1.1× 148 1.5× 5 574
Gelareh Abulwerdi United States 6 364 1.4× 106 0.8× 155 1.3× 26 0.2× 179 1.8× 14 704
Macarena Hernández‐Jiménez Spain 14 324 1.2× 174 1.4× 120 1.0× 32 0.3× 106 1.1× 26 803
Maria Gloria Pittelli Italy 10 284 1.1× 88 0.7× 176 1.5× 190 1.6× 97 1.0× 17 639
Marit Wiersma Netherlands 13 336 1.3× 89 0.7× 29 0.2× 40 0.3× 92 0.9× 17 686
Jiaxin Li China 13 320 1.2× 165 1.3× 44 0.4× 38 0.3× 40 0.4× 48 593
Francesca Potenza Italy 5 398 1.5× 133 1.0× 55 0.5× 29 0.3× 244 2.5× 7 676
Wichit Suthammarak United States 9 534 2.1× 75 0.6× 100 0.8× 36 0.3× 122 1.2× 13 734

Countries citing papers authored by Robert Gharavi

Since Specialization
Citations

This map shows the geographic impact of Robert Gharavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Gharavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Gharavi more than expected).

Fields of papers citing papers by Robert Gharavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Gharavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Gharavi. The network helps show where Robert Gharavi may publish in the future.

Co-authorship network of co-authors of Robert Gharavi

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Gharavi. A scholar is included among the top collaborators of Robert Gharavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Gharavi. Robert Gharavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Goel, Sanjay, Susanna V. Ulahannan, Anthony J. Olszanski, et al.. (2022). A phase 1b, multicenter, dose-escalation study of subasumstat (TAK-981) in combination with pembrolizumab in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 2506–2506. 2 indexed citations
2.
Dudek, Arkadiusz Z., Dejan Juric, Afshin Dowlati, et al.. (2021). 476 First-in-human phase 1/2 study of the first-in-class SUMO-activating enzyme inhibitor TAK-981 in patients with advanced or metastatic solid tumors or relapsed/refractory lymphoma: phase 1 results. Regular and Young Investigator Award Abstracts. A505–A506. 10 indexed citations
3.
Landsburg, Daniel J., Radhakrishnan Ramchandren, Kevin R. Kelly, et al.. (2018). A Pooled Analysis of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients Treated with the Dual PI3K and HDAC Inhibitor Fimepinostat (CUDC-907), Including Patients with MYC-Altered Disease. Blood. 132(Supplement 1). 4184–4184. 1 indexed citations
4.
5.
Oki, Yasuhiro, Kevin R. Kelly, Ian W. Flinn, et al.. (2017). CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial. Haematologica. 102(11). 1923–1930. 102 indexed citations
6.
7.
Gharavi, Robert, William D. Hedrich, Hongbing Wang, & Hazem E. Hassan. (2015). Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions. Pharmaceutical Research. 32(8). 2477–502. 17 indexed citations
8.
Liu, Dong, Yongqing Zhang, Robert Gharavi, et al.. (2015). The mitochondrial uncoupler DNP triggers brain cell mTOR signaling network reprogramming and CREB pathway up‐regulation. Journal of Neurochemistry. 134(4). 677–692. 57 indexed citations
9.
Wang, Ying, Peethambaran Arun, Yanling Wei, et al.. (2014). Repeated Blast Exposures Cause Brain DNA Fragmentation in Mice. Journal of Neurotrauma. 31(5). 498–504. 25 indexed citations
10.
Yap, Jeremy L., Huabo Wang, Angela Hu, et al.. (2012). Pharmacophore identification of c-Myc inhibitor 10074-G5. Bioorganic & Medicinal Chemistry Letters. 23(1). 370–374. 62 indexed citations
11.
Arun, Peethambaran, et al.. (2011). Studies on blast traumatic brain injury using in-vitro model with shock tube. Neuroreport. 22(8). 379–384. 59 indexed citations
12.
Liu, Dong, Robert Gharavi, M. G. R. PITTA, Marc Gleichmann, & Mark P. Mattson. (2009). Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons. NeuroMolecular Medicine. 11(1). 28–42. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron Long Breakdown of academic impact, for papers by Xiongjin Chen Breakdown of academic impact, for papers by Hassina Massudi Breakdown of academic impact, for papers by Gelareh Abulwerdi Breakdown of academic impact, for papers by Macarena Hernández‐Jiménez Breakdown of academic impact, for papers by Maria Gloria Pittelli Breakdown of academic impact, for papers by Marit Wiersma Breakdown of academic impact, for papers by Jiaxin Li Breakdown of academic impact, for papers by Francesca Potenza Breakdown of academic impact, for papers by Wichit Suthammarak
Rankless by CCL
2026